Topic:

Partnering

Latest Headlines

Latest Headlines

Recipharm and CTC unite for early-stage trials

Contract developer Recipharm and CTC Clinical Trial Consultants are joining forces to offer combined Phase I services, pooling their capabilities in manufacturing and trial conduction.

Evotec pockets a payment in its Boehringer partnership

German contractor Evotec has notched another milestone in its years-long arrangement with Boehringer Ingelheim, netting €1 million ($1.4 million) after moving a respiratory compound into preclinical study.

ClinicalRM teams up with an Ohio network for clinical trials

CRO ClinicalRM has signed a deal with the Ohio Clinical Trials Collaborative to join forces in a co-marketing arrangement, looking to expand its role in the state's drug and device development scene.

Bristol-Myers enlists Duke's CRO to help it share trial data

Bristol-Myers Squibb has tapped Duke University's in-house CRO to pitch in on clinical trial transparency, asking the organization's researchers to independently review requests for shared data.

Covance is creating an OkCupid for molecules

As last week's BIO conference well illustrated, biotech companies go to great lengths to flaunt their assets in front of potential partners from Big Pharma. Global CRO Covance is developing a system it believes can make that process more efficient: an online platform that allows drug developers to securely list their up-for-license molecules for would-be collaborators.

Pfizer to partner with South African university on preclinical research

The partnership may include the use of Pfizer's genetically modified animal models to evaluate the safety and efficacy of therapeutic molecules in oncology, inflammation, immunology, central nervous system and cardiovascular system disorders.

Mersana grabs a $792M ADC development pact with Merck KGaA

Mersana Therapeutics has inked another antibody-drug conjugate development pact, this time with the R&D team at Merck KGaA in Germany.

Merck targets Alzheimer's in $526M collaboration on new cognitive treatment

Last summer, Bionomics struck a $172 million discovery deal on new pain meds with Merck. And now the pharma giant has come back to the bargaining table to bag a much bigger collaboration with the Adelaide, Australia-based biotech, paying $20 million upfront and promising up to $506 million in milestones to collaborate on a new Alzheimer's drug.

UC San Diego to lead $2M statewide brain research project

The University of California, San Diego is launching its own project to supplement President Obama's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, unveiled in April 2013.

Tips for a successful relationship with a CRO

More and more device companies are turning to contract research organizations for assistance in managing their clinical trials, something that is commonplace in the biopharma world. The first ever Partnerships in Medical Device Trials Conference was recently held in Chicago.